Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 2 of 6

Charles Gore, chief executive of the Hepatitis C Trust

If patient access to new hepatitis C drugs is unduly restricted, legal challenges against the NHS could follow, says Charles Gore, chief executive of the Hepatitis C Trust

Source  The Hepatitis C Trust